Treatment Response of Patients with Erythrodermic Psoriasis after Switching to Guselkumab
mediaposted on 2021-01-29, 08:38 authored by Cheng-Ying Chiang, Tsen-Fang Tsai
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.